- Home
- IDYA vs AMBP Comparison
IDYA vs AMBP Comparison
Compare IDYA & AMBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- AMBP
- Stock Information
- Founded
- IDYA 2015
- AMBP 2021
- Country
- IDYA United States
- AMBP Luxembourg
- Employees
- IDYA N/A
- AMBP N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- AMBP Containers/Packaging
- Sector
- IDYA Health Care
- AMBP Industrials
- Exchange
- IDYA Nasdaq
- AMBP Nasdaq
- Market Cap
- IDYA 2.3B
- AMBP 2.4B
- IPO Year
- IDYA 2019
- AMBP N/A
- Fundamental
- Price
- IDYA $31.60
- AMBP $3.54
- Analyst Decision
- IDYA Buy
- AMBP Hold
- Analyst Count
- IDYA 17
- AMBP 6
- Target Price
- IDYA $48.20
- AMBP $4.22
- AVG Volume (30 Days)
- IDYA 1.3M
- AMBP 1.5M
- Earning Date
- IDYA 11-04-2025
- AMBP 10-23-2025
- Dividend Yield
- IDYA N/A
- AMBP 10.93%
- EPS Growth
- IDYA N/A
- AMBP N/A
- EPS
- IDYA N/A
- AMBP N/A
- Revenue
- IDYA $7,000,000.00
- AMBP $5,346,000,000.00
- Revenue This Year
- IDYA $90.17
- AMBP $11.61
- Revenue Next Year
- IDYA $219.42
- AMBP $2.17
- P/E Ratio
- IDYA N/A
- AMBP N/A
- Revenue Growth
- IDYA N/A
- AMBP 10.34
- 52 Week Low
- IDYA $13.45
- AMBP $2.50
- 52 Week High
- IDYA $33.64
- AMBP $4.78
- Technical
- Relative Strength Index (RSI)
- IDYA 63.75
- AMBP 38.94
- Support Level
- IDYA $28.17
- AMBP $3.65
- Resistance Level
- IDYA $33.64
- AMBP $4.25
- Average True Range (ATR)
- IDYA 1.70
- AMBP 0.14
- MACD
- IDYA 0.33
- AMBP -0.02
- Stochastic Oscillator
- IDYA 72.58
- AMBP 0.00
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
About AMBP Ardagh Metal Packaging S.A.
Ardagh Metal Packaging SA is a supplier of infinitely recyclable, sustainable, metal beverage cans and ends to brand owners. The company deals with multiple categories of products including beer, carbonated soft drinks, energy drinks, hard seltzers, juices, pre-mixed cocktails, teas, sparkling waters, and wine. Its segment includes Europe and the Americas. It derives a majority of its revenue from the Americas.